is semaglutide bad for your liver disease: Diabetes and weight loss drug may be effective Why are GLP-1 agonists being

In the future, even if there is widespread insurance coverage, we do not know if there will be a cap on how long the drug is approved for individual patients

2024 Oct 15;44(11):NP809-NP818 Functional and Aesthetic Periorbital, Ocular Adnexal and Ocular Surface Changes Linked to GLP-1 Receptor Agonists

If you pick up something that's not good for you, it tells you on the label

Autophagy in atherosclerosis: A cell survival and death phenomenon with therapeutic potential

Without strength training stimulus, the body will catabolize muscle tissue alongside fat, leading to a worse body composition outcome despite the number on the scale going down